Perioperative Management of Ulcerative Colitis: A Systematic Review

被引:11
作者
Lee, Kate E. E. [1 ]
Faye, Adam S. [2 ]
Vermeire, Severine [3 ]
Shen, Bo [4 ,5 ]
机构
[1] Duke Univ, Dept Med, Med Ctr, Durham, NC USA
[2] NYU, Div Gastroenterol, Grossman Sch Med, New York, NY USA
[3] Univ Hosp Leuven, Div Gastroenterol & Hepatol, Leuven, Belgium
[4] Columbia Univ, Digest Dis & Surg Inst, Dept Surg, Ctr Inflammatory Bowel Dis,New York Presbyterian,I, New York, NY USA
[5] Columbia Univ, Digest Dis & Surg Inst, Ctr Inflammatory Bowel Dis, Dept Surg,Irving Med Ctr, Suite 843,161 Ft Washington Ave, New York, NY 10032 USA
关键词
Endoscopy; Inflammatory bowel disease; Perioperative; Postoperative; Preoperative; Resection; Surgery; Ulcerative colitis; INFLAMMATORY-BOWEL-DISEASE; PREOPERATIVE INFLIXIMAB USE; POUCH-ANAL ANASTOMOSIS; POSTOPERATIVE INFECTIOUS COMPLICATIONS; VENOUS THROMBOEMBOLISM PROPHYLAXIS; NECROSIS FACTOR THERAPY; ANTI-TNF THERAPY; CROHNS-DISEASE; MAINTENANCE THERAPY; PRACTICE GUIDELINES;
D O I
10.1097/DCR.0000000000002588
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND:Patients with ulcerative colitis may require colectomy for severe disease unresponsive or refractory to pharmacological therapy. Managing ulcerative colitis is complicated because there are many factors at play, including patient optimization and treatment, as the guidance varies on the ideal perioperative use of corticosteroids, immunomodulators, biologics, and small molecule agents. OBJECTIVE:A systematic literature review was performed to describe the current status of perioperative management of ulcerative colitis. DATA SOURCES:PubMed and Cochrane databases were used. STUDY SELECTION:Studies published between January 2000 and January 2022, in any language, were included. Articles regarding pediatric or endoscopic management were excluded. INTERVENTIONS:Perioperative management of ulcerative colitis was included. MAIN OUTCOME MEASURES:Successful management, including reducing surgical complication rates, was measured. RESULTS:A total of 121 studies were included in this review, including 23 meta-analyses or systematic reviews, 25 reviews, and 51 cohort studies. LIMITATIONS:Qualitative review including all study types. The varied nature of study types precludes quantitative comparison. CONCLUSION:Indications for colectomy in ulcerative colitis include severe disease unresponsive to medical treatment and colitis-associated neoplasia. Urgent colectomy has a higher mortality rate than elective colectomy. Corticosteroids are associated with postsurgical infectious complications and should be stopped or weaned before surgery. Biologics are not associated with adverse postoperative effects and do not necessarily need to be stopped preoperatively. Additionally, the clinician must assess individuals' comorbidities, nutrition status, and risk of venous thromboembolism. Nutritional imbalance should be corrected, ideally at the preoperative period. Postoperatively, corticosteroids can be tapered on the basis of the length of preoperative corticosteroid use.
引用
收藏
页码:S5 / S19
页数:15
相关论文
共 121 条
  • [1] Corticosteroids and immunomodulators: Postoperative infectious complication risk in inflammatory bowel disease patients
    Aberra, FN
    Lewis, JD
    Hass, D
    Rombeau, JL
    Osborne, B
    Lichtenstein, GR
    [J]. GASTROENTEROLOGY, 2003, 125 (02) : 320 - 327
  • [2] Perioperative Dietary Therapy in Inflammatory Bowel Disease (Publication with Expression of Concern)
    Adamina, Michel
    Gerasimidis, Konstantinos
    Sigall-Boneh, Rotem
    Zmora, Oded
    van Overstraeten, Anthony de Buck
    Campmans-Kuijpers, Marjo
    Ellul, Pierre
    Katsanos, Konstantinos
    Kotze, Paulo Gustavo
    Noor, Nurulamin
    Schafli-Thurnherr, Judit
    Vavricka, Stephan
    Wall, Catherine
    Wierdsma, Nicolette
    Yassin, Nuha
    Lomer, Miranda
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 (04) : 431 - 444
  • [3] Prevalence and risk factors for venous thromboembolic complications in the Swiss Inflammatory Bowel Disease Cohort
    Alatri, Adriano
    Schoepfer, Alain
    Fournier, Nicolas
    Engelberger, Rolf Peter
    Safroneeva, Ekaterina
    Vavricka, Stephan
    Biedermann, Luc
    Calanca, Luca
    Mazzolai, Lucia
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (10) : 1200 - 1205
  • [4] Ali UA, 2014, DIS COLON RECTUM, V57, P663, DOI 10.1097/DCR.0000000000000099
  • [5] Etiopathogenesis, Prevention, and Treatment of Thromboembolism in Inflammatory Bowel Disease
    Alkim, Huseyin
    Koksal, Ali Riza
    Boga, Salih
    Sen, Ilker
    Alkim, Canan
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2017, 23 (06) : 501 - 510
  • [6] Perioperative and Postoperative Management of Patients With Crohn's Disease and Ulcerative Colitis
    Barne, Edward L.
    Lightner, Amy L.
    Regueiro, Miguel
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (06) : 1356 - 1366
  • [7] Peri-Procedural Management of Oral Anticoagulants in the DOAC Era
    Barnes, Geoffrey D.
    Mouland, Erin
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 2018, 60 (06) : 600 - 606
  • [8] ECCO-ESCP Consensus on Surgery for Crohn's Disease
    Bemelman, Willem A.
    Warusavitarne, Janindra
    Sampietro, Gianluca M.
    Serclova, Zuzana
    Zmora, Oded
    Luglio, Gaetano
    van Overstraeten, Anthony de Buck
    Burke, John P.
    Buskens, Christianne J.
    Colombo, Francesco
    Dias, Jorge Amil
    Eliakim, Rami
    Elosua, Tomas
    Gecim, I. Ethem
    Kolacek, Sanja
    Kierkus, Jaroslaw
    Kolho, Kaija-Leena
    Lefevre, Jeremie H.
    Millan, Monica
    Panis, Yves
    Pinkney, Thomas
    Russell, Richard K.
    Shwaartz, Chaya
    Vaizey, Carolynne
    Yassin, Nuha
    D'Hoore, Andre
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 (01) : 1 - 16
  • [9] Extended Venous Thromboembolism Prophylaxis After Elective Surgery for IBD Patients: Nomogram-Based Risk Assessment and Prediction from Nationwide Cohort
    Benlice, Cigdem
    Holubar, Stefan D.
    Gorgun, Emre
    Stocchi, Luca
    Lipman, Jeremy M.
    Kalady, Matthew F.
    Champagne, Bradley J.
    Steele, Scott R.
    [J]. DISEASES OF THE COLON & RECTUM, 2018, 61 (10) : 1170 - 1179
  • [10] Tofacitinib for Biologic-Experienced Hospitalized Patients With Acute Severe Ulcerative Colitis: A Retrospective Case-Control Study
    Berinstein, Jeffrey A.
    Sheehan, Jessica L.
    Dias, Michael
    Berinstein, Elliot M.
    Steiner, Calen A.
    Johnson, Laura A.
    Regal, Randolph E.
    Allen, John I.
    Cushing, Kelly C.
    Stidham, Ryan W.
    Bishu, Shrinivas
    Kinnucan, Jami A. R.
    Cohen-Mekelburg, Shirley A.
    Waljee, Akbar K.
    Higgins, Peter D. R.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (10) : 2112 - +